亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Ⅱ型糖尿病獼猴部分靶器官中Th1/Th2型細(xì)胞因子表達(dá)分析

        2016-01-15 09:41:20陳姍姍,羅啟慧,曾文
        關(guān)鍵詞:型糖尿病獼猴細(xì)胞因子

        Ⅱ型糖尿病獼猴部分靶器官中Th1/Th2型細(xì)胞因子表達(dá)分析

        陳姍姍1?, 羅啟慧1?, 曾文2, 程安春1,3, 劉文濤1, 史良琴1, 陳正禮1,2*

        ( 1.四川農(nóng)業(yè)大學(xué)動(dòng)物醫(yī)學(xué)院,動(dòng)物疾病與人類(lèi)健康中心四川省重點(diǎn)實(shí)驗(yàn)室,四川 雅安625014;2.四川普萊美生物科技有限公司/

        國(guó)家實(shí)驗(yàn)獼猴種源基地,四川 雅安625014;3.四川農(nóng)業(yè)大學(xué)預(yù)防獸醫(yī)研究所,成都611130)

        摘要檢測(cè)Ⅱ型糖尿病獼猴部分靶器官中Ⅰ型輔助T細(xì)胞(Th1)因子IL-2和IFN-γ以及Ⅱ型輔助T細(xì)胞(Th2)因子IL-4、IL-10的表達(dá)及分布變化情況,研究Th1/Th2型細(xì)胞因子在Ⅱ型糖尿病發(fā)病中的變化。?、蛐吞悄虿〖敖】但J猴胰腺、肝、腎和心臟,通過(guò)石蠟切片、常規(guī)染色觀察病理變化,同時(shí)采用免疫組織化學(xué)SABC法檢測(cè)各靶器官I(mǎi)L-2、IFN-γ、IL-4和IL-10的表達(dá)及分布情況。病理結(jié)果顯示:糖尿病獼猴肝血竇增寬伴中性粒細(xì)胞浸潤(rùn),腎、心臟和胰腺細(xì)胞呈不同程度腫脹、萎縮及壞死。免疫組織化學(xué)結(jié)果顯示:在腎中Th1型細(xì)胞因子IFN-γ表達(dá)水平高于健康組(P<0.01)并分布于近曲小管、遠(yuǎn)曲小管及集合管。胰腺中IFN-γ表達(dá)水平與健康組相比差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),陽(yáng)性產(chǎn)物分布于胰島部及外分泌部。胰腺及腎中Th1型細(xì)胞因子IL-2表達(dá)水平與健康組相比差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。胰腺及腎中Th2型細(xì)胞因子IL-4表達(dá)水平顯著低于健康組(P<0.01),陽(yáng)性產(chǎn)物分布于遠(yuǎn)曲小管、胰腺胰島及外分泌部。在胰腺、腎、肝及心臟中,Th2型細(xì)胞因子IL-10表達(dá)水平顯著高于健康組(P<0.01),陽(yáng)性產(chǎn)物分布于近曲小管、遠(yuǎn)曲小管、胰腺胰島、胰腺外分泌部、心肌細(xì)胞及肝細(xì)胞的胞質(zhì)中。Th1/Th2型細(xì)胞因子在Ⅱ型糖尿病(type 2 diabetes mellitus, T2DM)的發(fā)病過(guò)程中發(fā)生了顯著變化。

        關(guān)鍵詞Th1/Th2; 細(xì)胞因子; Ⅱ型糖尿病; 獼猴

        中圖分類(lèi)號(hào)R 363.21; S 852.35文獻(xiàn)標(biāo)志碼A

        Expression of Th1/Th2 cytokines in partial target organs of type 2 diabetes mellitus rhesus monkey. Journal of ZhejiangUniversity(Agric. & LifeSci.), 2015,41(3):302-308

        Chen Shanshan1?, Luo Qihui1?, Zeng Wen2, Cheng Anchun1,3, Liu Wentao1, Shi Liangqin1, Chen Zhengli1,2*(1.KeyLaboratoryofAnimalDiseaseandHumanHealthofSichuanProvince,CollegeofVeterinaryMedicine,SichuanAgriculturalUniversity,Ya’an625014,Sichuan,China; 2.SichuanPrimedBiologicalTechnologyCo.,Ltd/NationalExperimentalMacaqueReproduceLaboratory,Ya’an625014,Sichuan,China; 3.InstituteofPreventiveVeterinaryMedicine,SichuanAgriculturalUniversity,Chengdu611130,China)

        SummaryType 2 diabetes mellitus (T2DM) is a disease caused by carbohydrate metabolism disturbance, insulin resistance and reduction of insulin. Many studies confirmed that the disequilibrium of Th1/Th2 cells concerned with T2DM. IL-2 and IFN-γ mediate the growth of Th1 cells which induce cellular immunity. IL-4 and IL-10 are key mediators of Th2 cells which play an important role in humoral immunity. The principal goal of the present research is to detect the changes of Th1/Th2 cytokines in the pathogenesis of T2DM.

        Five male healthy rhesus monkeys and five male T2DM rhesus monkeys induced by high-fat diets were used in the study. All rhesus monkeys had been checked without any infections such as bacteria and parasite before trials. After induced for 24 months, the fasting plasma glucose (FPG) mean value of all T2DM rhesus monkeys was higher than 7.0 mmol/L, and that of the control rhesus monkeys was below 6.11 mmol/L. Typical symptoms of type 2 diabetes mellitus were also observed in T2DM rhesus monkeys. The FPG met the WHO and ADA standards for type 2 diabetes mellitus.

        Animals were scarified after ketamine anesthesia. Target organs (liver, kidney, heart and pancreas) were fixed in paraformaldehyde, embedded in paraffin and sliced. The pathological changes were studied by hematoxylin-eosin staining, and the expressions of IL-2, IFN-γ, IL-4 and IL-10 were observed by immunohistochemistry. Mean density was measured by IPP 6.0 (Image-pro plus 6.0) to evaluate their variation.

        Neutrophil cell infiltration which means chronic inflammation was observed in hepatic sinusoid of T2DM rhesus monkeys, and hepatic sinusoid of T2DM was wider than healthy rhesus monkeys. Different degrees of cellular swell and atrophy as well as necrosis were found in kidney, heart and pancreas. All the tested organs in the study were damaged in the process of T2DM.

        IL-2, IL-4 and IFN-γ were only expressed in kidney and pancreas, and IL-10 was expressed in all the four organs. IL-2 was only expressed in langerhans islet and kidney tubules, but IFN-γ, IL-4 and IL-10 were expressed in endocrine and exocrine pancreas, kidney tubules. IL-10 was also expressed in hepatic and myocardial cell. The expression of IFN-γ and IL-10 were significantly increased (P<0.01), but IL-4 was decreased oppositely (P<0.01). The expression of IL-2 in pancreas and kidney had no difference between T2DM and health rhesus monkeys (P>0.05).

        In conclusion, IL-2, Th1 cytokines, has no significant change, but IFN-γ of Th1 cell is expressed higher in T2DM. Simultaneously, IL-4 and IL-10, Th2 cytokines, change oppositely. Inflammation exists in the process of T2DM. Difference distribution and level of Th1/Th2 cytokines between T2DM and health rhesus monkeys show that Th1/Th2 cell disequilibrium is key mediators in T2DM. According to the complex changes of cytokines of Th1/Th2 cells, it needs further researches to define the relationship of Th1/Th2 balance with T2DM.

        Key wordsTh1/Th2; cytokines; type 2 diabetes mellitus; rhesus monkey

        Ⅱ型糖尿病(type 2 diabetes mellitus, T2DM)是一種由環(huán)境、遺傳等多因素引起的,以胰島素分泌缺陷和胰島素抵抗為特征的代謝性綜合征。免疫功能紊亂是Ⅱ型糖尿病發(fā)病的重要原因,Marques-Vidal等[1]研究發(fā)現(xiàn),T2DM病人外周血液中部分細(xì)胞因子水平較高。大量研究[2-4]證實(shí),T2DM動(dòng)物及人外周血液中細(xì)胞因子水平發(fā)生了不同的變化。其中大部分細(xì)胞因子由Th1或Th2細(xì)胞分泌,而Th1/Th2平衡失調(diào)與許多疾病的發(fā)生密切相關(guān).Ⅰ型糖尿病和糖尿病視網(wǎng)膜病均存在Th1/Th2向Th1亞群轉(zhuǎn)化的現(xiàn)象[5-7],提示Th1/Th2平衡失調(diào)可能是導(dǎo)致T2DM發(fā)生的重要因素。不少關(guān)于糖尿病及相關(guān)并發(fā)癥治療的報(bào)道,均觀察到Th1/Th2平衡失調(diào)有所緩解[6,8-11]。Th1細(xì)胞以分泌IL-2、IFN-γ為主,介導(dǎo)細(xì)胞免疫反應(yīng);Th2細(xì)胞以分泌IL-4、IL-10為主,介導(dǎo)體液免疫反應(yīng)。未見(jiàn)細(xì)胞免疫及體液免疫在T2DM發(fā)病進(jìn)程中的關(guān)系及T2DM發(fā)病過(guò)程中是否存在Th1/Th2平衡漂移的報(bào)道,因此T2DM是否存在Th1/Th2平衡漂移具有非常重要的研究?jī)r(jià)值。

        目前,缺乏以獼猴T2DM模型為研究對(duì)象的相關(guān)報(bào)道。因此本實(shí)驗(yàn)通過(guò)飼喂高脂飼料,建立川西亞種獼猴T2DM模型。該模型具有血糖規(guī)律、病理特征與在人類(lèi)糖尿病患者中觀察到的臨床特征較為相似的優(yōu)勢(shì),避免了藥物造模過(guò)程中毒副作用強(qiáng)、穩(wěn)定性差的問(wèn)題,能真正很好地模擬人類(lèi)糖尿病發(fā)展的長(zhǎng)期緩慢進(jìn)程及由此引起的全身機(jī)體變化的問(wèn)題,科學(xué)性較強(qiáng)。在模型建立成功的基礎(chǔ)上,對(duì)T2DM動(dòng)物部分靶器官組織病變,以及Th1細(xì)胞分泌的IL-2、IFN-γ,Th2細(xì)胞分泌的IL-4、IL-10表達(dá)及分布進(jìn)行觀察,探討T2DM是否存在Th1/Th2平衡漂移,以期為該疾病的治療提供新思路。

        1材料與方法

        1.1材料

        1.1.1實(shí)驗(yàn)動(dòng)物5只通過(guò)高脂飲食誘導(dǎo)建立的川西亞種獼猴T2DM模型,5只健康川西亞種獼猴(獼猴在實(shí)驗(yàn)前檢疫合格,內(nèi)容包括:體檢,2次結(jié)核桿菌試驗(yàn),寄生蟲(chóng)、沙門(mén)菌、致賀氏菌和B病毒檢查;獼猴單只飼喂,解剖前無(wú)外傷)均由四川農(nóng)業(yè)大學(xué)實(shí)驗(yàn)動(dòng)物工程技術(shù)中心/國(guó)家實(shí)驗(yàn)獼猴種源基地提供[動(dòng)物使用許可證為SCXK(川):2013-105]。

        T2DM川西亞種獼猴模型符合美國(guó)糖尿病學(xué)會(huì)(ADA)和世界衛(wèi)生組織(WHO)2006年糖尿病診斷標(biāo)準(zhǔn):典型糖尿病癥狀(多尿、多飲和體質(zhì)量下降),空腹血糖(fasting plasma glucose,FPG)≥7.0 mmol/L或餐后2 h血糖(2hPG)≥11.1 mmol/L,為糖尿病;7.77 mmol/L <2hPG<11.1 mmol/L時(shí)為糖耐量損傷(impaired glucose tolerance,IGT),6.11 mmol/L≤FPG<6.99 mmol/L時(shí)為空腹血糖損傷(impaired fasting glucose,IFG),FPG<6.11 mmol/L且2hPG<7.77 mmol/L,為正常,具體指標(biāo)及空腹血糖變化情況(表1)參見(jiàn)本課題組已有文獻(xiàn)[12-13]報(bào)道。實(shí)驗(yàn)中對(duì)動(dòng)物的處置符合中華人民共和國(guó)科學(xué)技術(shù)部《關(guān)于善待實(shí)驗(yàn)動(dòng)物的指導(dǎo)性意見(jiàn)》的規(guī)定。

        1.1.2儀器設(shè)備石蠟切片機(jī)(日本Leica公司),CH20BIMF200光學(xué)顯微鏡(日本Olympus公司),Nikon50i-BF生物數(shù)碼顯微鏡(日本Nikon光學(xué)株式會(huì)社),冰箱,恒溫培養(yǎng)箱等。

        1.1.3主要試劑IL-2、IL-10兔抗人多克隆抗體,即用型SABC試劑盒(組成:5% BSA、生物素標(biāo)志的山羊抗兔IgG和SABC),DAB顯色試劑盒,多聚賴(lài)氨酸均購(gòu)自武漢博士德生物工程有限公司;IL-4、IFN-γ兔抗人多克隆抗體購(gòu)自北京博奧森生物技術(shù)有限公司;0.01 mol/L pH 6.0檸檬酸緩沖液;0.02 mol/L pH 7.2磷酸鹽緩沖液(phosphate buffered saline,PBS)。

        1.2方法

        1.2.1實(shí)驗(yàn)動(dòng)物處理于高脂飼料誘導(dǎo)前和誘導(dǎo)后第2、3、5、7、10、11、12、15、16、18、19、20、22和24月,禁食16 h,從后肢股靜脈采血,分析空腹血糖(FPG)濃度。

        高脂飲食誘導(dǎo)24個(gè)月后,用氯胺酮麻醉動(dòng)物,經(jīng)頸動(dòng)脈放血將動(dòng)物處死并解剖。取出肝、胰腺、腎、心臟固定于4%多聚甲醛中24~48 h。

        1.2.2石蠟切片制作及常規(guī)染色取材沖水24 h后用于常規(guī)石蠟組織包埋,玻片經(jīng)多聚賴(lài)氨酸處理后,連續(xù)切片,厚為5 μm,每個(gè)樣品切21張備用,并進(jìn)行常規(guī)蘇木精-伊紅法(hematoxylin-eosin,HE)染色。

        1.2.3免疫組織化學(xué)SABC法切片脫蠟至水后,用檸檬酸緩沖液微波抗原修復(fù),4次,間隔6 min,PBS洗3次;3% H2O2室溫孵育50 min,蒸餾水洗3次,PBS洗1次;5% BSA,37 ℃孵育50 min;IL-2、IL-4、IL-10和IFN-γ兔多克隆抗體稀釋液(1∶200),4 ℃孵育過(guò)夜,室溫復(fù)溫30 min后,PBS洗4次;生物素化山羊抗兔IgG,37 ℃孵育40 min,PBS洗3次;SABC,37 ℃孵育20 min,PBS洗3次,蒸餾水洗1次;DAB藍(lán)色顯色液顯色,脫水、透明、封片。

        2結(jié)果與分析

        2.1空腹血糖濃度變化及主要病理變化

        10只獼猴空腹血糖濃度變化詳見(jiàn)表1,可見(jiàn)經(jīng)過(guò)24個(gè)月高脂飲食誘導(dǎo)后,T2DM組獼猴空腹血糖平均水平已超過(guò)7.0 mmol/L,符合WHO和ADA公布的糖尿病判斷標(biāo)準(zhǔn)。

        表1 高脂膳食誘導(dǎo)對(duì)川西亞種獼猴空腹血糖的影響

        T2DM組肝、腎、胰腺及心臟發(fā)生了不同程度的炎性反應(yīng)。肝:肝血竇增寬伴大量中性粒細(xì)胞浸潤(rùn),肝細(xì)胞腫脹,部分細(xì)胞核濃縮壞死。腎:腎小球萎縮,腎小管上皮細(xì)胞核濃縮,重度腫脹伴壞死脫落,部分區(qū)域可見(jiàn)大量上皮細(xì)胞管型。心臟:心肌細(xì)胞萎縮,間質(zhì)增寬且成分增多。胰腺:胰島細(xì)胞中度到重度腫脹、空泡變性,局部細(xì)胞溶解壞死,外分泌部細(xì)胞核濃縮,細(xì)胞萎縮,腺管結(jié)構(gòu)不清晰(圖1).

        2.2免疫組織化學(xué)染色結(jié)果

        從圖2~5可以看出,免疫組織化學(xué)染色陽(yáng)性反應(yīng)呈藍(lán)黑色。IL-10在心肌、腎、肝、胰腺中有表達(dá),IL-2、IL-4、IFN-γ只在腎和胰腺中有表達(dá)。與健康獼猴相比,T2DM模型獼猴胰腺中IL-4表達(dá)水平顯著降低(P<0.01),IL-10顯著升高(P<0.01),而IFN-γ表達(dá)差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),三者于胰島部及外分泌部均有表達(dá)。腎中,IL-4分布于遠(yuǎn)曲小管且表達(dá)水平顯著降低(P<0.01),IL-10分布于近曲小管且表達(dá)水平顯著升高(P<0.01),而IFN-γ分布于近曲小管、遠(yuǎn)曲小管及集合管且表達(dá)水平顯著增強(qiáng)(P<0.01)。與胰腺和腎表達(dá)水平相似,心臟及肝中IL-10的表達(dá)也顯著升高(P<0.01)。同時(shí),IL-2在健康組和糖尿病組間差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),僅表達(dá)于胰腺胰島外周、腎近曲小管、遠(yuǎn)曲小管及集合管。

        圖1 糖尿病獼猴肝、腎、心和胰腺病理變化 Fig.1 Pathological changes of liver, kidney, heart and pancreas in T2DM rhesus monkey

        **表示在0.01水平差異有高度統(tǒng)計(jì)學(xué)意義。 Double asterisk (**) indicate statistically highly significant difference at the 0.01 probability level。 圖2 IFN-γ、IL-2、IL-4和IL-10在Ⅱ型糖尿病獼猴靶器官陽(yáng)性產(chǎn)物中的平均吸光度 Fig.2 Mean density of IFN-γ, IL-2, IL-4 and IL-10 positive staining in target organ of T2DM rhesus monkey

        圖3 IFN-γ、IL-2、IL-4和IL-10在胰腺的表達(dá)分布 Fig.3 Expression and distribution of IFN-γ, IL-2, IL-4 and IL-10 in pancreas of T2DM rhesus monkey

        圖4 IFN-γ、IL-2、IL-4和IL-10在腎的表達(dá)分布 Fig.4 Expression and distribution of IFN-γ, IL-2, IL-4 and IL-10 in kidney of T2DM rhesus monkey

        圖5 IL-10在肝和心的表達(dá)分布 Fig.5 Expression and distribution of IL-10 in liver and heart of T2DM rhesus monkey

        3討論

        大量研究表明,Th1/Th2平衡失調(diào)與肥胖誘導(dǎo)的糖尿病及其并發(fā)癥發(fā)生關(guān)系密切,是許多疾病的重要致病因素[14]。T2DM的主要致病機(jī)制是胰島素抵抗與胰島素分泌受損,免疫功能低下是胰島素抵抗發(fā)生的關(guān)鍵因素。病理結(jié)果顯示T2DM靶器官發(fā)生了不同程度炎性反應(yīng),這與體內(nèi)細(xì)胞因子表達(dá)分布變化密切相關(guān)。同時(shí),肝、心臟、腎及胰腺細(xì)胞腫脹壞死的現(xiàn)象證實(shí)它們是T2DM發(fā)病過(guò)程中受損的靶器官。

        干細(xì)胞移植治療T2DM后,發(fā)現(xiàn)炎性細(xì)胞因子水平降低,且T2DM免疫功能缺陷得到了恢復(fù)[15]。用混合營(yíng)養(yǎng)物質(zhì)治療STZ小鼠糖尿病模型后,檢測(cè)到Th1細(xì)胞因子水平下降,而Th2細(xì)胞因子IL-10水平升高[16]。這些研究證明,Th1/Th2型細(xì)胞因子在糖尿病發(fā)病或治療過(guò)程中發(fā)生了顯著變化,與糖尿病關(guān)系密切。Cheng等[17]在使用富胍免疫抑制性寡核苷酸治療膳食誘導(dǎo)肥胖小鼠后,降低了胰島素抵抗反應(yīng),這是通過(guò)調(diào)節(jié)Th1/Th2平衡來(lái)達(dá)到的。因此,在T2DM發(fā)病過(guò)程中Th1/Th2型細(xì)胞因子的變化值得關(guān)注。本實(shí)驗(yàn)結(jié)果發(fā)現(xiàn)肝、腎、心肌及胰腺細(xì)胞的胞質(zhì)IFN-γ、IL-4、IL-10水平發(fā)生了變化。其中,IFN-γ表達(dá)升高與Mahmoud等[3]在對(duì)T2DM患者外周血液中T淋巴細(xì)胞因子的研究結(jié)果一致;同時(shí),IL-10表達(dá)水平升高與Zhang等[18]對(duì)Ⅱ型糖尿病腎病患者血漿IL-10研究所得結(jié)果一致,Al-Shukaili等[19]對(duì)T2DM患者的血液學(xué)研究也得到了同樣的結(jié)果,但是該研究未發(fā)現(xiàn)T細(xì)胞亞群發(fā)生變化。

        IFN-γ可促進(jìn)M1巨噬細(xì)胞分化,導(dǎo)致促炎性細(xì)胞因子產(chǎn)生,加重炎性反應(yīng)。IL-4可誘導(dǎo)M2巨噬細(xì)胞分化,產(chǎn)生抗感染性細(xì)胞因子[20]。本研究結(jié)果發(fā)現(xiàn),在T2DM的發(fā)病過(guò)程中IL-4表達(dá)減弱,說(shuō)明機(jī)體抗感染效應(yīng)減弱,即炎性反應(yīng)加強(qiáng)。同時(shí),從各細(xì)胞因子在不同靶器官的分布差異可推斷出,細(xì)胞因子是通過(guò)血液運(yùn)輸?shù)礁靼衅鞴賲⑴c炎性反應(yīng)的。

        眾所周知,Th1細(xì)胞以分泌IL-2、IFN-γ為主,Th2細(xì)胞以分泌IL-4、IL-10為主。從分泌變化的角度來(lái)看,Th1細(xì)胞分泌的IFN-γ增多,而IL-2不變,可表現(xiàn)為T(mén)h1細(xì)胞增多或功能增強(qiáng)。同樣,Th2細(xì)胞分泌的IL-10增多,而IL-4減少,與Th1 2個(gè)細(xì)胞因子變化相比較,可知Th1細(xì)胞亞群增殖強(qiáng)于Th2細(xì)胞。另外,IFN-γ與IL-4存在相互拮抗的關(guān)系,兩者平衡可影響Th1/Th2細(xì)胞亞群分化[21]。已知IFN-γ可促進(jìn)Th1細(xì)胞增殖,也可抑制IL-4對(duì)B細(xì)胞分化的促進(jìn)作用。同時(shí),IL-4可抑制Th1細(xì)胞增殖來(lái)拮抗IFN-γ。本研究結(jié)果中T2DM組Th1細(xì)胞因子IFN-γ表達(dá)較健康組高,說(shuō)明Th1細(xì)胞增殖作用加強(qiáng);同時(shí)Th2細(xì)胞因子IL-4表達(dá)減弱,說(shuō)明其促B細(xì)胞分化抑制Th1細(xì)胞增殖的作用減弱,從而可推斷出Th1細(xì)胞亞群的增殖強(qiáng)于Th2細(xì)胞。

        通過(guò)本實(shí)驗(yàn)可確定的是T2DM獼猴體內(nèi)Th1細(xì)胞亞群增殖加強(qiáng),而IL-4的降低可能會(huì)抵消IL-10升高所代表的Th2細(xì)胞增殖現(xiàn)象,因此無(wú)法確定Th2細(xì)胞亞群的變化??梢?jiàn),Th1/Th2亞群變化與T2DM的發(fā)生關(guān)系密切,但兩者因果關(guān)系需要進(jìn)一步實(shí)驗(yàn)證明。由于細(xì)胞因子間的作用太過(guò)復(fù)雜,僅通過(guò)細(xì)胞因子的變化來(lái)研究Th1/Th2平衡變化在T2DM發(fā)病過(guò)程中的作用還遠(yuǎn)遠(yuǎn)不夠,后續(xù)工作可考慮檢測(cè)CD4、CD8及CD3的比值來(lái)探討在T2DM發(fā)病過(guò)程中Th1/Th2平衡的變化方向。

        總之,本實(shí)驗(yàn)通過(guò)對(duì)T2DM獼猴部分靶器官中IFN-γ、IL-2、IL-10、IL-4的表達(dá)研究發(fā)現(xiàn),Th1/Th2型細(xì)胞因子表達(dá)水平發(fā)生了不同變化。Th1細(xì)胞因子IL-2表達(dá)水平無(wú)顯著變化,而IFN-γ表達(dá)水平升高;Th2細(xì)胞因子IL-4水平降低,而IL-10水平升高。Th1/Th2的顯著變化表明其相關(guān)因子與T2DM的發(fā)病進(jìn)程密切相關(guān)。

        參考文獻(xiàn)(References):

        [1]Marques-Vidal P, Schmid R, Bochud M,etal. Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.PloSONE, 2012,7(12):e51768.

        [2]Costantini S, Capone F, Guerriero E,etal. Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection.PloSONE, 2012,7(6):e39486.

        [4]Badawi A, Klip A, Haddad P,etal. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.Diabetes,MetabolicSyndromeandObesity:TargetsandTherapy, 2010,3:173-186.

        [5]顧國(guó)浩,彭群新.Th1/Th2細(xì)胞的免疫功能變化及其意義.國(guó)外醫(yī)學(xué):臨床生物化學(xué)與檢驗(yàn)學(xué)分冊(cè),2003,24(6):333-334.

        Gu G H, Peng Q X. Immune function changes and significance of Th1/Th2 cells.ForeignMedicalSciences:SectionofClinicalBiochemistryandLaboratoryMedicine, 2003,24(6):333-334. (in Chinese)

        [6]Hassan G A, Sliem H A, Ellethy A T,etal. Role of immune system modulation in prevention of type 1 diabetes mellitus.IndianJournalofEndocrinologyandMetabolism, 2012,16(6):904-909.

        [7]Liu J, Shi B, He S,etal. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy.MolecularVision, 2010,16:2931-2938.

        [8]Groen B, Links T P, Lefrandt J D,etal. Aberrant pregnancy adaptations in the peripheral immune response in type 1 diabetes: A rat model.PloSONE, 2013,8(6):e65490.

        [5]李啟成.清末比附援引與罪刑法定存廢之爭(zhēng)——以《刑律草案簽注》為中心[J].中國(guó)社會(huì)科學(xué),2013,(11):104-120.

        [9]Zhang C L, Gui L, Xu Y J,etal. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.InternationalImmunopharmacology, 2013,16(4):451-456.

        [10]Ezquer F, Ezquer M, Contador D,etal. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.StemCells, 2012,30(8):1664-1674.

        [11]Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C,etal. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time.AnnalsofMedicine:Helsinki, 2010,42(6):426-438.

        [12]曾文.恒河猴川西亞種生物學(xué)特性背景數(shù)據(jù)建立及在新藥評(píng)估中的應(yīng)用研究.雅安,四川:四川農(nóng)業(yè)大學(xué),2010.

        Zeng W. Establishment of a biological background database of a subspecies of rhesus monkey (Macacamulattalasiotis) and its application in new drug evaluation. Ya’an, Sichuan: Sichuan Agriculture University, 2010. (in Chinese with English abstract)

        [13]Gong L, Zeng W, Yang Z,etal. Comparison of the clinical manifestations of type 2 diabetes mellitus between rhesus monkey (Macacamulattalasiotis) and human being.Pancreas, 2013,42(3):537-542.

        [14]姚金晶,陳宜濤.Th1/Th2平衡調(diào)節(jié)與疾病發(fā)生的研究進(jìn)展.現(xiàn)代生物醫(yī)學(xué)進(jìn)展,2009,9(13):2597-2600.

        Yao J J, Chen Y T. Advances of regulation Th1/Th2 type cytokines balance in human disease。ProgressinModernBiomedicine, 2009,9(13):2597-2600. (in Chinese with English abstract)

        [15]Zhao Y, Jiang Z, Zhao T,etal. Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: Phase Ⅰ/Ⅱ clinical trial.BMCMedicine, 2013,11:160.

        [16]Chang Y, Zhang G Z, Piao S L,etal. Protective effects of combined micronutrients on islet beta-cells of streptozotocin-induced diabetic mice.InternationalJournalforVitaminandNutritionResearch, 2009,79(2):104-116.

        [17]Cheng X, Wang J, Xia N,etal. A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation.EMBOMolecularMedicine, 2012,4(10):1112-1125.

        [18]Zhang C, Xiao C, Wang P,etal. The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy.HumanImmunology, 2014,75(4):289-296.

        [19]Al-Shukaili A, Al-Ghafri S, Al-Marhoobi S,etal. Analysis of inflammatory mediators in type 2 diabetes patients.InternationalJournalofEndocrinology, 2013,2013:976810.

        [20]Winer S, Winer D A. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance.ImmunologyandCellBiology, 2012,90(8):755-762.

        [21]Pernis A, Gupta S, Gollob K J,etal. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells.Science, 1995,269(5221):245-247.

        猜你喜歡
        型糖尿病獼猴細(xì)胞因子
        小獼猴征集令
        抗GD2抗體聯(lián)合細(xì)胞因子在高危NB治療中的研究進(jìn)展
        小獼猴話(huà)跆拳道
        小獼猴偵探社
        小獼猴偵探社
        八段錦對(duì)Ⅱ型糖尿病防治作用的理論探討
        常規(guī)心電圖ST—T段壓低對(duì)老年Ⅱ型糖尿病冠心病發(fā)生的預(yù)測(cè)價(jià)值
        Ⅱ型糖尿病合并心腦血管疾病27例的療效觀察
        阿托伐他汀對(duì)高血脂伴Ⅱ型糖尿病患者血管內(nèi)皮細(xì)胞的保護(hù)作用
        急性心肌梗死病人細(xì)胞因子表達(dá)及臨床意義
        91精品国产闺蜜国产在线| AV中文码一区二区三区| 洗澡被公强奷30分钟视频| 女人的精水喷出来视频| 自拍偷区亚洲综合第一页| 久久AⅤ天堂Av无码AV| 精品久久综合亚洲伊人| 亚洲人成电影在线播放| 91精品亚洲成人一区二区三区| 少妇隔壁人妻中文字幕| 精品国产亚欧无码久久久| 亚洲中文无码永久免| 国产精品女人呻吟在线观看| 久久狼精品一区二区三区| 日本高清色一区二区三区| 久久99亚洲综合精品首页| 亚洲色图+国产精品| 一个人看的视频www免费| 色欲av伊人久久大香线蕉影院| 护士人妻hd中文字幕| 一个人的视频免费播放在线观看| 久久国产乱子伦精品免费强| 久久午夜无码鲁丝片直播午夜精品| 国产精品成人va在线观看| 国模gogo无码人体啪啪| 日韩美女av一区二区| 亚洲综合偷拍一区二区| 亚洲无码vr| 国产人在线成免费视频麻豆| 国产午夜亚洲精品午夜鲁丝片| 国产精品嫩草99av在线| 久久精品国产成人午夜福利| 一本大道久久a久久综合精品| 亚洲国产成人av第一二三区| 精品的一区二区三区| 国产精品美女白浆喷水| 国产高清在线精品免费| 久久夜色精品国产噜噜av| 国语自产偷拍在线观看| 国产高潮流白浆视频在线观看| 无码制服丝袜中文字幕|